Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hybrid LT-A/CT-B holotoxin for use as an adjuvant

Hybrid LT-A/CT-B holotoxin for use as an adjuvant

US Patent 7063852 · Granted Jun 20, 2006

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mutated e. coli enterotoxins as anti-inflammatory agents2025
Primary mesenchymal stem cells as a vaccine platform2019
Vaccine2019
Mutant enterotoxin effective as a non-toxic oral adjuvant2002
Mutant enterotoxin effective as a non-toxic adjuvant2002
Pharmaceutical composition of escherichia coli heat-labile enterotoxin adjuvant 2002
Oral immunization with transgenic plants2002
Double mutant enterotoxin for use as an adjuvant2000
Mutant enterotoxin effective as a non-toxic oral adjuvant2000
Production of the E. coli LT-B enterotoxin subunit1994
Production of the E. coli LT-B enterotoxin subunit in S. typhi1992
Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsula1989